Frequently Asked Questions
What are the purine levels in Sugars Sugar Granulated White Name Brand?
While exact purine measurements for Sugars Sugar Granulated White Name Brand are limited, it is classified as None for gout. This rating draws on established scientific consensus and typical values for its food group. Consult our full review for dietary recommendations.
Does Sugars Sugar Granulated White Name Brand contain fructose?
Sugars Sugar Granulated White Name Brand contains virtually no fructose (less than 0.1g per 100g), so fructose is not a concern for gout with this food. Fructose itself can raise uric acid through its own metabolic pathway, yet this food contributes very little fructose.
Can I eat Sugars Sugar Granulated White Name Brand with gout?
Sugars Sugar Granulated White Name Brand is generally safe for people with gout. may contain moderate purines. Most gout guidance treats purine levels below 50 mg per 100g as low-risk. It fits into a balanced gout-conscious diet, with the caveat to follow your doctor's individual guidance.
What food category does Sugars Sugar Granulated White Name Brand belong to?
Sugars Sugar Granulated White Name Brand is classified under Grains in our gout food database. Knowing its food group helps you weigh it appropriately within your broader gout diet plan. Browse other grains items to compare purine and fructose levels across similar foods.
What are other gout-safe foods like Sugars Sugar Granulated White Name Brand?
If you enjoy Sugars Sugar Granulated White Name Brand, you may also want to explore other grains items rated SAFE for gout in our database. Aim for same-category options that are low in both purine (under 50 mg/100g) and fructose (under 2g/100g). Browse our grains category page for full comparisons.
Data Quality
This entry uses T2-level data:
At least one dimension is directly measured; the other is based on scientific consensus.
Sources include USDA FoodData Central (public domain, CC0 1.0), the USDA+ODS-NIH Database for the Purine Content of Foods Release 2.0 (2025), Kaneko et al. Biol Pharm Bull 2014, and ACR/EULAR clinical guidelines.